Valuation: Cello Health plc

Market Cap 179M 156M 144M 134M 254M 17.06B 257M 1.72B 670M 8.37B 672M 657M 28.98B P/E 2018
18.1x
P/E 2019 -155x
Enterprise Value 182M 159M 147M 136M 259M 17.4B 262M 1.75B 683M 8.54B 685M 670M 29.56B EV / Sales 2018
0.66x
EV / Sales 2019 0.88x
Free-Float
-
Yield 2018
3.47%
Yield 2019 1.6%
Manager TitleAgeSince
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 51 2020-08-12
Director/Board Member 47 2023-12-14
Date Insider Type Main position Quantity % Market Cap.
20-03-29Free

Founder

495,000 0.4656%
20-03-29Free 80,000 0.0752%
20-03-29Free

Chief Operating Officer

265,000 0.2492%

Financials

2018 2019
Net sales 166M 145M 133M 124M 235M 15.79B 238M 1.59B 620M 7.75B 622M 608M 26.83B 167M 146M 134M 124M 237M 15.91B 240M 1.6B 624M 7.8B 626M 613M 27.03B
Net income 6.62M 5.78M 5.33M 4.94M 9.4M 631M 9.51M 63.58M 24.78M 310M 24.85M 24.31M 1.07B -943K -824K -759K -704K -1.34M -89.94M -1.36M -9.06M -3.53M -44.13M -3.54M -3.46M -153M
Net Debt -6.34M -5.54M -5.1M -4.73M -9.01M -605M -9.12M -60.92M -23.74M -297M -23.81M -23.29M -1.03B 3.58M 3.13M 2.88M 2.67M 5.08M 341M 5.14M 34.36M 13.39M 167M 13.43M 13.14M 580M
Logo Cello Health plc
Cello Health plc, formerly Cello Group plc, is a United Kingdom-based healthcare and consumer strategic marketing company. The Company is engaged in providing market research, consulting and direct marketing services. The Company provides a range of biotech, diagnostics, devices and other non-healthcare clients. The Company operates through two segments: Cello Health and Cello Signal. The Cello Health Division provides market research, consulting and communications services principally to the Company's pharmaceutical and healthcare clients. The Cello Signal Division provides market research and direct communications services to the Company's consumer facing clients. The Company delivers its services from office networks in the United Kingdom, the United States and Singapore.
Employees
-
Sector
-